Advertisement

Topics

Probable carcinogen in heart drug may have been present since 2012, reveals EMA

11:15 EDT 19 Jul 2018 | The Pharmaceutical Journal

An impurity found in valsartan-containing medicines manufactured in China could have been present since 2012, according to the European Medicines Agency.

Original Article: Probable carcinogen in heart drug may have been present since 2012, reveals EMA

NEXT ARTICLE

More From BioPortfolio on "Probable carcinogen in heart drug may have been present since 2012, reveals EMA"

Advertisement
Quick Search
Advertisement
Advertisement